title: Use of Direct Oral Anticoagulants in Patients With Atrial Fibrillation and Valvular Heart Lesions.
authors.affiliation: Albert Einstein College of Medicine at Montefiore Hospital, Bronx, NY Department of Biomedical Engineering, University of Texas at Austin, TX Texas Cardiac Arrhythmia Institute at St. David's Medical Center, Austin, TX Department of Cardiology, University of Foggia, Foggia, Italy dibbia@gmail.com.
authors.forename: Luigi
authors.initials: L
authors.lastname: Di Biase
mesh_terms: D000284:Administration, Oral; D000925:Anticoagulants / Q000008:administration & dosage* / Q000009:adverse effects; D001281:Atrial Fibrillation / Q000097:blood / Q000150:complications / Q000188:drug therapy* / Q000401:mortality; D001777:Blood Coagulation / Q000187:drug effects*; D002986:Clinical Trials as Topic; D019317:Evidence-Based Medicine; D006349:Heart Valve Diseases / Q000097:blood / Q000150:complications / Q000188:drug therapy* / Q000401:mortality; D006470:Hemorrhage / Q000139:chemically induced; D006801:Humans; D012307:Risk Factors; D020521:Stroke / Q000097:blood / Q000209:etiology / Q000401:mortality / Q000517:prevention & control*; D016896:Treatment Outcome
chemical_list: D000925:Anticoagulants
keywords: anticoagulants; atrial fibrillation; treatment; valvular heart disease